Literature DB >> 10579683

Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies.

G M El Maghraby1, A C Williams, B W Barry.   

Abstract

Deformable vesicles and traditional liposomes were compared as delivery systems for oestradiol to elucidate possible mechanisms of drug delivery through human skin. Accordingly, epidermal permeation of oestradiol from optimized deformable vesicles and traditional liposome formulations was studied under low dose non-occluded conditions. Five mechanisms were investigated. A free drug mechanism compared low-dose permeation through skin with drug release determined after separation of the free drug. Penetration enhancement was researched by studying skin pretreatment with empty vesicles. Improved drug uptake by skin was monitored by dipping stratum corneum into different formulations for 10 min and determining drug uptake. The possibility that intact vesicles permeate through the epidermis was tested by comparing permeation from 136-nm vesicles with that from >500-nm vesicles, assuming that penetration depends on vesicle size. The possibility that different entrapment efficiencies in alternative formulations could be responsible for the difference in delivery was also evaluated. Lipid vesicles improved the skin delivery of oestradiol compared with delivery from an aqueous control. Maximum flux (Jmax) was increased 14- to 17-fold by use of deformable vesicles and 8.2- to 9.8-fold by use of traditional liposomes. Deformable vesicles were thus superior to traditional liposomes. Drug release was negligible over the period during which skin flux was maximum. Pretreatment with empty vesicles resulted in an enhancement ratio of 4.3 for pure phosphatidylcholine (PC) vesicles but the enhancement ratio ranged from only 0.8 to 2.4 for other formulations. Vesicles increased drug uptake into the stratum corneum 23- to 29-fold. Relative flux values obtained from small and large vesicles were similar. No correlation was found between entrapment efficiency and skin delivery. The results showed no evidence of a free drug mechanism, but revealed a possible penetration-enhancing effect for pure PC vesicles, although this was not the only mechanism operating. The positive uptake suggested that lipid vesicles increased drug partitioning into the skin. The data provided no evidence for in-vitro liposome penetration through skin as distinct from vesicle penetration into the stratum corneum.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579683     DOI: 10.1211/0022357991776813

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  18 in total

1.  Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers.

Authors:  Sureewan Duangjit; Praneet Opanasopit; Theerasak Rojanarata; Tanasait Ngawhirunpat
Journal:  AAPS PharmSciTech       Date:  2012-12-14       Impact factor: 3.246

2.  Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation.

Authors:  Fang Guo; Jinping Wang; Man Ma; Fengping Tan; Nan Li
Journal:  J Mater Sci Mater Med       Date:  2015-04-01       Impact factor: 3.896

3.  Lipid Vesicles for the Skin Delivery of Diclofenac: Cerosomes vs. Other Lipid Suspensions.

Authors:  Anahita Fathi-Azarbayjani; Kai Xin Ng; Yew Weng Chan; Sui Yung Chan
Journal:  Adv Pharm Bull       Date:  2015-03-05

4.  Penetration enhancers in proniosomes as a new strategy for enhanced transdermal drug delivery.

Authors:  Gamal M El Maghraby; Amal A Ahmed; Mohamed A Osman
Journal:  Saudi Pharm J       Date:  2014-05-12       Impact factor: 4.330

5.  Transdermal delivery of an anti-cancer drug via w/o emulsions based on alkyl polyglycosides and lecithin: design, characterization, and in vivo evaluation of the possible irritation potential in rats.

Authors:  Aliaa Nabil ElMeshad; Mina Ibrahim Tadros
Journal:  AAPS PharmSciTech       Date:  2010-12-09       Impact factor: 3.246

6.  Novel Self-assembled, Gel-core Hyaluosomes for Non-invasive Management of Osteoarthritis: In-vitro Optimization, Ex-vivo and In-vivo Permeation.

Authors:  Wessam M El-Refaie; Yosra S R Elnaggar; Magda A El-Massik; Ossama Y Abdallah
Journal:  Pharm Res       Date:  2015-03-17       Impact factor: 4.200

7.  Tocopheryl phosphate mixture (TPM) as a novel lipid-based transdermal drug delivery carrier: formulation and evaluation.

Authors:  Paul D Gavin; Mahmoud El-Tamimy; Hooi Hong Keah; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

8.  Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery.

Authors:  Jadupati Malakar; Suma Oomen Sen; Amit Kumar Nayak; Kalyan Kumar Sen
Journal:  Saudi Pharm J       Date:  2012-02-21       Impact factor: 4.330

9.  Enhanced transdermal delivery of salbutamol sulfate via ethosomes.

Authors:  Ehab R Bendas; Mina I Tadros
Journal:  AAPS PharmSciTech       Date:  2007-12-14       Impact factor: 3.246

10.  Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations.

Authors:  P Loan Honeywell-Nguyen; Sonia Arenja; Joke A Bouwstra
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.